BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 5757238)

  • 1. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 2. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
    Busnardo B; Accordi F; Debiasi S
    Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of immunosuppressive therapy on the long acting thyroid stimulator (LATS) and the clinical picture in patients with localized myxedema and exophthalmus].
    Depisch D; Höfer R; Schatz H
    Wien Klin Wochenschr; 1969 Jan; 81(1):8-10. PubMed ID: 5818436
    [No Abstract]   [Full Text] [Related]  

  • 5. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema.
    From E; Diederichsen H; Heydenreich G; Nielsen OS
    Dan Med Bull; 1973 Dec; 20(6):188-91. PubMed ID: 4591336
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)].
    Studer H
    Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
    Tourneur R; Letonturier P; Sénécal P
    MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
    Friis T
    Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-acting thyroid stimulator].
    Titov VN
    Klin Med (Mosk); 1969 Oct; 47(10):31-9. PubMed ID: 4915396
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
    McKenzie JM; McCullagh EP
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-acting thyroid stimulator (LATS) in thyroid pathology].
    Winand R
    Rev Med Liege; 1970 Aug; 25(15):478-82. PubMed ID: 5468466
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical significance of plasma thyroid-stimulating ctivity in hyperthyroidism.
    Hoffmann MJ; Hetzel BS
    Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4169740
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical significance of plasma thyroid-stimulating activity in hyperthyroidism.
    Hoffmann MJ; Hetzel BS
    Australas Ann Med; 1966 Aug; 15(3):204-9. PubMed ID: 4168752
    [No Abstract]   [Full Text] [Related]  

  • 19. The long-acting thyroid stimulator and thyroid disease.
    Kriss JP
    Adv Intern Med; 1970; 16():135-54. PubMed ID: 4247613
    [No Abstract]   [Full Text] [Related]  

  • 20. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum].
    Muramoto E; Nicolau W; Ikeda E; de Assis LM; Pieroni RR
    AMB Rev Assoc Med Bras; 1972 Oct; 18(10):379-88. PubMed ID: 4539360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.